Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Filed Aug 10, 2020 · 10-Q · 41 days after period end · 0001447362-20-000169
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $12.72M | $10.74M | $3.98M |
| Net Income | -$1.38M | -$1.27M | -$3.16M |
| EPS Diluted | -$0.08 | -$1.05 | -$2.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 10, 2020 · 41 d after period end
